Zomedica Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZOM research report →
Companywww.zomedica.com
Zomedica Corp. , a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals.
- CEO
- Larry C. Heaton II
- IPO
- 2017
- Employees
- 144
- HQ
- Ann Arbor, MI, US
Price Chart
Valuation
- Market Cap
- $95.35M
- P/E
- -4.22
- P/S
- 2.78
- P/B
- 0.86
- EV/EBITDA
- -3.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 66.29%
- Op Margin
- -71.97%
- Net Margin
- -65.78%
- ROE
- -19.16%
- ROIC
- -21.56%
Growth & Income
- Revenue
- $32.03M · 17.39%
- Net Income
- $-81,858,000 · -74.23%
- EPS
- $-0.08 · -66.67%
- Op Income
- $-84,353,000
- FCF YoY
- 41.99%
Performance & Tape
- 52W High
- $0.20
- 52W Low
- $0.02
- 50D MA
- $0.11
- 200D MA
- $0.13
- Beta
- 1.16
- Avg Volume
- 8.54M
Get TickerSpark's AI analysis on ZOM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 17, 25 | Rowe Jeffrey M | buy | 731,368 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 34,725 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 4,265 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 68,000 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 100,647 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 500,000 |
| Mar 17, 25 | Williams Rodney James | buy | 100,000 |
| Mar 17, 25 | Jordan Scott | buy | 300,000 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 34,725 |
| Mar 17, 25 | Rowe Jeffrey M | buy | 4,265 |
Our ZOM Coverage
We haven't published any research on ZOM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ZOM Report →